Casdin Capital, LLC: summary

Casdin Capital, LLC reported 43 positions with a reported value of $2.00B in its 13F for Q2 2026. Compared with Q1 2026: 6 new positions, 3 exited.

Top positions

• REVOLUTION MEDICINES INC COM
• Relay Therapeutics Inc
• GENEDX HOLDINGS CORP
• BioLife Solutions Inc
• Illumina Inc
• Standard BioTools Inc
• STRUCTURE THERAPEUTICS INC
• Denali Therapeutics Inc
• Neurogene Inc
• Beam Therapeutics Inc